MSCL Satellos Bioscience Inc.

5.762USD8.240 CAD · TSX-3.06%Mkt Cap: 122.25M USDP/E: —

Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company us…